IDEAYA Biosciences, Inc.
IDYA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $207,834 | $0 | $0 | $7,000 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $1,030 | $1,233 | $1,133 | $643 |
| Gross Profit | $206,804 | -$1,233 | -$1,133 | $6,357 |
| % Margin | 99.5% | – | – | 90.8% |
| R&D Expenses | $82,993 | $74,226 | $70,886 | $140,183 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $15,359 | $13,347 | $12,370 | $10,312 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $98,352 | $87,573 | $83,256 | $150,495 |
| Operating Income | $108,452 | -$88,806 | -$84,389 | -$144,138 |
| % Margin | 52.2% | – | – | -2,059.1% |
| Other Income/Exp. Net | $10,792 | $11,315 | $12,211 | $13,826 |
| Pre-Tax Income | $119,244 | -$77,491 | -$72,178 | -$130,312 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $119,244 | -$77,491 | -$72,178 | -$130,312 |
| % Margin | 57.4% | – | – | -1,861.6% |
| EPS | 1.35 | -0.88 | -0.82 | -1.49 |
| % Growth | 253.4% | -7.3% | 45% | – |
| EPS Diluted | 1.33 | -0.88 | -0.82 | -1.49 |
| Weighted Avg Shares Out | 89,657 | 88,472 | 88,356 | 87,341 |
| Weighted Avg Shares Out Dil | 89,691 | 88,472 | 88,356 | 87,341 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,792 | $11,315 | $12,211 | $13,826 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,030 | $1,233 | $1,133 | $643 |
| EBITDA | $120,274 | -$76,258 | -$71,045 | -$129,669 |
| % Margin | 57.9% | – | – | -1,852.4% |